Skip to main content
. 2025 Feb 20;15(3):129. doi: 10.3390/bios15030129
BAL Bronchoalveolar Lavage
CAP Community-acquired Pneumonia
CBI Chronic Bronchial Infection
COPD Chronic Obstructive Pulmonary Disease
DRA Disulfide-reducing Agent
DTT Dithiothreitol
GFP Green Fluorescent Protein
HAP Hospital-acquired Pneumonia
HQQ 2-heptyl-4-hydroxyquinoline
HspX Heat Shock Protein X
ICU Intensive Care Unit
LAMP Loop-mediated Isothermal Amplification
LAMP-LFB Loop-mediated isothermal Amplification combined with a label-based Lateral Flow Biosensor
LC-MS/MS Liquid Chromatography coupled to Mass Spectrometry
LFB Lateral Flow Biosensors
LFIAs Lateral Flow Immunoassays
LOD Limit of Detection
LOQ Limit of Quantification
LRTIs Lower Respiratory Tract Infections
MCDA Multiple Cross Displacement Amplification
MCDA-LFB Multiple Cross Displacement Amplification combined with a label-based Lateral Flow Biosensor
mLAMP-LFIA Multiplex Loop-mediated Isothermal Amplification combined with a label-based Lateral Flow Immuno-Assay biosensor
NAAT Nucleic Acid Amplification Tests
NAC N-acetyl Cysteine
NS Not State
PCR Polymerase Chain Reaction
PL Polymorphonuclear Leukocytes
PQS 2-heptyl-3-hydroxy-4-quinolone
PYO Pyocyanin
QS Quorum Sensing
RSV Respiratory Syncytial Virus
SEC Squamous Epithelial Cells
SPR Surface Plasmon Resonance
VAP Ventilator-associated Pneumonia